• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CENTRIFUGAL PUMP HEADS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CENTRIFUGAL PUMP HEADS Back to Search Results
Model Number 164275
Device Problem Use of Device Problem (1670)
Patient Problems Hemolysis (1886); Injury (2348); Blood Loss (2597)
Event Date 03/18/2019
Event Type  Injury  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
 
Event Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, a hemolysis of blood was found in the centrifugal pump head.As per user facility, their setting was around 1000 to 150 revolutions per minute (rpm).No abnormal sound was heard on the centrifugal drive motor during procedure and was advised that they are still using the system 1 with the roller pump as the primary pump.No known impact or consequence to patient.There was a delay for approximately 20 minutes.The product was changed out.The procedure was completed successfully.It is unknown if there was a blood loss.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations.  method code: 4114 - device not returned.Results code: 114 - operational problem identified.Conclusions code: 19 - cause traced to user.The actual sample was not returned for evaluation, and a thorough investigation could not be performed.The lot number was not provided; therefore, a retention sample could not be evaluated.The picture that was provided confirmed the event, possible root cause that could explain the observed failure mode are, clamping of the outlet port with the pump running, inadequate heparinization of the patient, extended use past the rated duration of 6 hours, and lack of a suitable recirculation line.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Event Description
Additional information was obtained from the user facility that the blood loss was around 800 cc.Per clinical review; approximately an hour into a cardiopulmonary bypass procedure the user facility team experienced what was considered a blood hemolysis event due to the centrifugal pump and the centrifugal drive motor.A photo was provided showing that it depicts a coagulation occurrence, and has been restated as such from the end user - a thrombus.Per user facility the only information regarding the coagulation measurements and heparin management made available was that at some time during the procedure the act was 459 seconds.The end-user also add that the drive motor and the disposable were both hot to the touch.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: (identification of event problem and evaluation codes 2348, 2597, 11).A third follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references conclusions code 11.).All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on april 03, 2019.Upon further investigation of the reported event, the following information is new and/or changed: (corrected describe event or problem).(date received by manufacturer).(indication that this is a follow-up report).(follow-up due to correction).A second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references (b)(4).All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Event Description
As per user facility, their setting was around 1000 to 1500 revolutions per minute (rpm).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CENTRIFUGAL PUMP HEADS
Type of Device
CENTRIFUGAL PUMP
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
MDR Report Key8480345
MDR Text Key140909118
Report Number1124841-2019-00089
Device Sequence Number1
Product Code KFM
UDI-Device Identifier00699753002333
UDI-Public(01)00699753002333
Combination Product (y/n)N
PMA/PMN Number
K112229
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup,Followup
Report Date 05/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number164275
Device Catalogue NumberN/A
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/19/2019
Initial Date FDA Received04/03/2019
Supplement Dates Manufacturer Received03/19/2019
04/21/2019
05/13/2019
Supplement Dates FDA Received04/03/2019
05/09/2019
05/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-